Literature DB >> 25182644

Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaques.

Gregory Q Del Prete1, Rebecca Shoemaker1, Kelli Oswald1, Abigail Lara1, Charles M Trubey1, Randy Fast1, Douglas K Schneider1, Rebecca Kiser1, Vicky Coalter1, Adam Wiles1, Rodney Wiles1, Brandi Freemire1, Brandon F Keele1, Jacob D Estes1, Octavio A Quiñones2, Jeremy Smedley3, Rhonda Macallister3, Rosa I Sanchez4, John S Wai4, Christopher M Tan5, W Gregory Alvord2, Daria J Hazuda4, Michael Piatak1, Jeffrey D Lifson6.   

Abstract

Nonhuman primate models are needed for evaluations of proposed strategies targeting residual virus that persists in HIV-1-infected individuals receiving suppressive combination antiretroviral therapy (cART). However, relevant nonhuman primate (NHP) models of cART-mediated suppression have proven challenging to develop. We used a novel three-class, six-drug cART regimen to achieve durable 4.0- to 5.5-log reductions in plasma viremia levels and declines in cell-associated viral RNA and DNA in blood and tissues of simian immunodeficiency virus SIVmac239-infected Indian-origin rhesus macaques, then evaluated the impact of treatment with the histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA; Vorinostat) on the residual virus pool. Ex vivo SAHA treatment of CD4(+) T cells obtained from cART-suppressed animals increased histone acetylation and viral RNA levels in culture supernatants. cART-suppressed animals each received 84 total doses of oral SAHA. We observed SAHA dose-dependent increases in acetylated histones with evidence for sustained modulation as well as refractoriness following prolonged administration. In vivo virologic activity was demonstrated based on the ratio of viral RNA to viral DNA in peripheral blood mononuclear cells, a presumptive measure of viral transcription, which significantly increased in SAHA-treated animals. However, residual virus was readily detected at the end of treatment, suggesting that SAHA alone may be insufficient for viral eradication in the setting of suppressive cART. The effects observed were similar to emerging data for repeat-dose SAHA treatment of HIV-infected individuals on cART, demonstrating the feasibility, utility, and relevance of NHP models of cART-mediated suppression for in vivo assessments of AIDS virus functional cure/eradication approaches.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25182644      PMCID: PMC4249371          DOI: 10.1128/AAC.03746-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  74 in total

1.  Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy.

Authors:  Mariko Horiike; Shingo Iwami; Makoto Kodama; Akihiko Sato; Yuji Watanabe; Mika Yasui; Yuki Ishida; Takeshi Kobayashi; Tomoyuki Miura; Tatsuhiko Igarashi
Journal:  Virology       Date:  2011-12-21       Impact factor: 3.616

2.  RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues.

Authors:  Fay Wang; John Flanagan; Nan Su; Li-Chong Wang; Son Bui; Allissa Nielson; Xingyong Wu; Hong-Thuy Vo; Xiao-Jun Ma; Yuling Luo
Journal:  J Mol Diagn       Date:  2012-01       Impact factor: 5.568

3.  Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques.

Authors:  Thorsten Demberg; Egidio Brocca-Cofano; Peng Xiao; David Venzon; Diego Vargas-Inchaustegui; Eun Mi Lee; Irene Kalisz; V S Kalyanaraman; Janet Dipasquale; Katherine McKinnon; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

4.  Ultrasensitive allele-specific PCR reveals rare preexisting drug-resistant variants and a large replicating virus population in macaques infected with a simian immunodeficiency virus containing human immunodeficiency virus reverse transcriptase.

Authors:  Valerie F Boltz; Zandrea Ambrose; Mary F Kearney; Wei Shao; Vineet N Kewalramani; Frank Maldarelli; John W Mellors; John M Coffin
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

5.  Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaques.

Authors:  Gregory Q Del Prete; Mary F Kearney; Jon Spindler; Ann Wiegand; Elena Chertova; James D Roser; Jacob D Estes; Xing Pei Hao; Charles M Trubey; Abigail Lara; Kyeongeun Lee; Chawaree Chaipan; Julian W Bess; Kunio Nagashima; Brandon F Keele; Rhonda Macallister; Jeremy Smedley; Vinay K Pathak; Vineet N Kewalramani; John M Coffin; Jeffrey D Lifson
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

6.  Significant genetic heterogeneity of the SIVmac251 viral swarm derived from different sources.

Authors:  Samantha L Strickland; Rebecca R Gray; Susanna L Lamers; Tricia H Burdo; Ellen Huenink; David J Nolan; Brian Nowlin; Xavier Alvarez; Cecily C Midkiff; Maureen M Goodenow; Kenneth Williams; Marco Salemi
Journal:  AIDS Res Hum Retroviruses       Date:  2011-06-28       Impact factor: 2.205

7.  Reduced inflammation and lymphoid tissue immunopathology in rhesus macaques receiving anti-tumor necrosis factor treatment during primary simian immunodeficiency virus infection.

Authors:  Brian Tabb; David R Morcock; Charles M Trubey; Octavio A Quiñones; Xing Pei Hao; Jeremy Smedley; Rhonda Macallister; Michael Piatak; Levelle D Harris; Mirko Paiardini; Guido Silvestri; Jason M Brenchley; W Gregory Alvord; Jeffrey D Lifson; Jacob D Estes
Journal:  J Infect Dis       Date:  2012-10-19       Impact factor: 5.226

8.  Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

Authors:  Liang Shan; Kai Deng; Neeta S Shroff; Christine M Durand; S Alireza Rabi; Hung-Chih Yang; Hao Zhang; Joseph B Margolick; Joel N Blankson; Robert F Siliciano
Journal:  Immunity       Date:  2012-03-08       Impact factor: 31.745

9.  A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model.

Authors:  Iart Luca Shytaj; Sandro Norelli; Barbara Chirullo; Alessandro Della Corte; Matt Collins; Jake Yalley-Ogunro; Jack Greenhouse; Nunzio Iraci; Edward P Acosta; Maria Letizia Barreca; Mark G Lewis; Andrea Savarino
Journal:  PLoS Pathog       Date:  2012-06-21       Impact factor: 6.823

10.  Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.

Authors:  N M Archin; A L Liberty; A D Kashuba; S K Choudhary; J D Kuruc; A M Crooks; D C Parker; E M Anderson; M F Kearney; M C Strain; D D Richman; M G Hudgens; R J Bosch; J M Coffin; J J Eron; D J Hazuda; D M Margolis
Journal:  Nature       Date:  2012-07-25       Impact factor: 49.962

View more
  36 in total

1.  Virologic and Immunologic Features of Simian Immunodeficiency Virus Control Post-ART Interruption in Rhesus Macaques.

Authors:  Zachary Strongin; Luca Micci; Rémi Fromentin; Justin Harper; Julia McBrien; Emily Ryan; Neeta Shenvi; Kirk Easley; Nicolas Chomont; Guido Silvestri; Mirko Paiardini
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

2.  Simian Immunodeficiency Virus SIVsab Infection of Rhesus Macaques as a Model of Complete Immunological Suppression with Persistent Reservoirs of Replication-Competent Virus: Implications for Cure Research.

Authors:  Dongzhu Ma; Cuiling Xu; Anthony R Cillo; Benjamin Policicchio; Jan Kristoff; George Haret-Richter; John W Mellors; Ivona Pandrea; Cristian Apetrei
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 3.  Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.

Authors:  Jay Rappaport; David J Volsky
Journal:  J Neurovirol       Date:  2015-05-02       Impact factor: 2.643

4.  Antiretroviral Therapy in Simian Immunodeficiency Virus-Infected Sooty Mangabeys: Implications for AIDS Pathogenesis.

Authors:  Francesca Calascibetta; Luca Micci; Diane Carnathan; Benton Lawson; Thomas H Vanderford; Steven E Bosinger; Kirk Easley; Ann Chahroudi; Joseph Mackel; Brandon F Keele; Samuel Long; Jeffrey Lifson; Mirko Paiardini; Guido Silvestri
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

5.  Wake me up before you go: a strategy to reduce the latent HIV reservoir.

Authors:  Nicolas Chomont; Afam A Okoye; David Favre; Lydie Trautmann
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

6.  Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral Therapy.

Authors:  Gregory Q Del Prete; Kelli Oswald; Abigail Lara; Rebecca Shoemaker; Jeremy Smedley; Rhonda Macallister; Vicky Coalter; Adam Wiles; Rodney Wiles; Yuan Li; Randy Fast; Rebecca Kiser; Bing Lu; Jim Zheng; W Gregory Alvord; Charles M Trubey; Michael Piatak; Claire Deleage; Brandon F Keele; Jacob D Estes; Joseph Hesselgesser; Romas Geleziunas; Jeffrey D Lifson
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

7.  Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.

Authors:  David Palesch; Steven E Bosinger; Maud Mavigner; James M Billingsley; Cameron Mattingly; Diane G Carnathan; Mirko Paiardini; Ann Chahroudi; Thomas H Vanderford; Guido Silvestri
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

8.  Short Communication: Comparative Evaluation of Coformulated Injectable Combination Antiretroviral Therapy Regimens in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Gregory Q Del Prete; Jeremy Smedley; Rhonda Macallister; Gregg S Jones; Bei Li; Jillian Hattersley; Jim Zheng; Michael Piatak; Brandon F Keele; Joseph Hesselgesser; Romas Geleziunas; Jeffrey D Lifson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-09       Impact factor: 2.205

Review 9.  Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.

Authors:  Mark Y Jeng; Ibraheem Ali; Melanie Ott
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-09-02       Impact factor: 8.250

10.  CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy.

Authors:  Emily K Cartwright; Lori Spicer; S Abigail Smith; David Lee; Randy Fast; Sara Paganini; Benton O Lawson; Melon Nega; Kirk Easley; Joern E Schmitz; Steven E Bosinger; Mirko Paiardini; Ann Chahroudi; Thomas H Vanderford; Jacob D Estes; Jeffrey D Lifson; Cynthia A Derdeyn; Guido Silvestri
Journal:  Immunity       Date:  2016-09-20       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.